Sangamo Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript
© -
Hi everyone, this is Marty Auster. I'm the lead SMID-Cap Biotech Analyst here at Crédit Suisse. I think -- I was mistaken, the last presentation thinking he was the last final one of the day. I believe this is the final presentation of the day.
I am happy to have Sangamo Therapeutics here with us today. I'm going to hand it over now to Sandy Macrae. Thank you, Sandy. Take it away.
Thank you. So if I can now share my screen. And make it -- there we go. So thank you. And during today's presentation, I'll be making forward-looking statements. So please refer to our latest filings with the SEC.
And we are Sangamo. We're Sangamo Therapeutics, where we're committed to translating groundbreaking science into genomic medicines that transform patients' lives. And all those parts are important. It's about the science. It's about making medicines. And it's about making
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
